Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Gefitinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Gefitinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Glecirasib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Glecirasib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Glumetinib	MET Inhibitor	Solid Tumour
Molecule Glumetinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Golvatinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Golvatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Icotinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Icotinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Infigratinib	FGFR Inhibitor	Solid Tumour
Molecule Infigratinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Ipatasertib	AKT Inhibitor	Solid Tumour
Molecule Ipatasertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Iruplinalkib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Iruplinalkib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Ivosidenib	RET / MET / KRAS / IDH Inhibitor	Solid Tumour
Molecule Ivosidenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Lapatinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Lapatinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Larotrectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Larotrectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Lazertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Lazertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor

Gefitinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Glecirasib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Glumetinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism MET Inhibitor
Golvatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Icotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Infigratinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Ipatasertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism AKT Inhibitor
Iruplinalkib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Ivosidenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism RET / MET / KRAS / IDH Inhibitor
Lapatinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Larotrectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Lazertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor

‹ 1 … 4 5 6 7 8 … 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Gefitinib

Glecirasib

Glumetinib

Golvatinib

Icotinib

Infigratinib

Ipatasertib

Iruplinalkib

Ivosidenib

Lapatinib

Larotrectinib

Lazertinib

Gefitinib

Glecirasib

Glumetinib

Golvatinib

Icotinib

Infigratinib

Ipatasertib

Iruplinalkib

Ivosidenib

Lapatinib

Larotrectinib

Lazertinib